EndoPredict® Extended Endocrine Trial (EXET)

Clinical trial NCT04016935 · TERMINATED

Trial details

NCT number: NCT04016935
Sponsor: Myriad Genetic Laboratories, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Primary Invasive Breast Cancer

Start date: 2019-07-02
Primary completion: 2022-03-31
Enrollment: 855

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.